Literature DB >> 12538693

MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse.

Elizabeth M Hiltbold1, Neil J Poloso, Paul A Roche.   

Abstract

Activation of CD4(+) Th cells requires their cognate interaction with APCs bearing specific relevant MHC class II-peptide complexes. This cognate interaction culminates in the formation of an immunological synapse that contains the various proteins and lipids required for efficient T cell activation. We now show that APC lipid raft membrane microdomains contain specific class II-peptide complexes and serve as platforms that deliver these raft-associated class II molecules to the immunological synapse. APC rafts are required for T cell:APC conjugate formation and T cell activation at low densities of relevant class II-peptide complexes, a requirement that can be overcome at high class II-peptide density. Analysis of confocal microscopy images revealed that over time APC lipid rafts, raft-associated relevant class II-peptide complexes, and even immunologically irrelevant class II molecules accumulate at the immunological synapse. As the immunological synapse matures, relevant class II-peptide complexes are sorted to a central region of the interface, while irrelevant class II molecules are excluded from this site. We propose that T cell activation is facilitated by recruitment of MHC class II-peptide complexes to the immunological synapse by virtue of their constitutive association with lipid raft microdomains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538693     DOI: 10.4049/jimmunol.170.3.1329

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.

Authors:  Anita H Undale; Peter J van den Elsen; Esteban Celis
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

2.  Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.

Authors:  Sanjay Khandelwal; Paul A Roche
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

3.  HIV-1 Nef binds a subpopulation of MHC-I throughout its trafficking itinerary and down-regulates MHC-I by perturbing both anterograde and retrograde trafficking.

Authors:  Ling Yi; Tilman Rosales; Jeremy J Rose; Bhabadeb Chowdhury; Bhabhadeb Chaudhury; Jay R Knutson; Sundararajan Venkatesan
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

Review 4.  MHC class II transport at a glance.

Authors:  Adam C Berger; Paul A Roche
Journal:  J Cell Sci       Date:  2009-01-01       Impact factor: 5.285

5.  Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.

Authors:  Even Walseng; Oddmund Bakke; Paul A Roche
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

Review 6.  MHC class II association with lipid rafts on the antigen presenting cell surface.

Authors:  Howard A Anderson; Paul A Roche
Journal:  Biochim Biophys Acta       Date:  2014-09-28

7.  Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.

Authors:  Kazuyuki Furuta; Satoshi Ishido; Paul A Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

8.  RAFTsomes containing epitope-MHC-II complexes mediated CD4+ T cell activation and antigen-specific immune responses.

Authors:  Qian Ding; Jian Chen; Xiaohui Wei; Wenqiang Sun; Junhua Mai; Yanzhu Yang; Yuhong Xu
Journal:  Pharm Res       Date:  2012-08-10       Impact factor: 4.200

9.  Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.

Authors:  Berta Bosch; Erica L Heipertz; James R Drake; Paul A Roche
Journal:  J Biol Chem       Date:  2013-03-26       Impact factor: 5.157

Review 10.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.